Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | chromobox protein, putative | 0.0077 | 0.1267 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0176 | 0.4627 | 0.5 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | 0.0057 | 0.0593 | 0.0358 |
Entamoeba histolytica | hypothetical protein | 0.004 | 0 | 0.5 |
Loa Loa (eye worm) | TAR-binding protein | 0.0134 | 0.3192 | 1 |
Echinococcus granulosus | chromobox protein 1 | 0.0077 | 0.1267 | 0.3968 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0107 | 0.2298 | 0.7201 |
Echinococcus multilocularis | chromobox protein 1 | 0.0077 | 0.1267 | 0.3968 |
Brugia malayi | chromobox protein homolog 3 | 0.0043 | 0.0116 | 0.0362 |
Echinococcus granulosus | tar DNA binding protein | 0.0134 | 0.3192 | 1 |
Toxoplasma gondii | hypothetical protein | 0.0054 | 0.0479 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0107 | 0.2298 | 0.7201 |
Schistosoma mansoni | tar DNA-binding protein | 0.0134 | 0.3192 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0134 | 0.3192 | 1 |
Echinococcus granulosus | chromobox protein 1 | 0.0077 | 0.1267 | 0.3968 |
Brugia malayi | MH2 domain containing protein | 0.0125 | 0.2903 | 0.9095 |
Trypanosoma brucei | mitochondrial DNA polymerase beta-PAK | 0.0158 | 0.402 | 0.3871 |
Loa Loa (eye worm) | hypothetical protein | 0.0073 | 0.1143 | 0.334 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.0334 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0107 | 0.2298 | 0.7095 |
Echinococcus multilocularis | chromobox protein 1 | 0.0077 | 0.1267 | 0.3968 |
Entamoeba histolytica | hypothetical protein | 0.004 | 0 | 0.5 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0125 | 0.2903 | 0.9061 |
Loa Loa (eye worm) | heterochromatin protein 1 | 0.0077 | 0.1267 | 0.3741 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0107 | 0.2298 | 0.7095 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0134 | 0.3192 | 1 |
Trypanosoma brucei | mitochondrial DNA polymerase beta | 0.0334 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0134 | 0.3192 | 1 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | 0.0158 | 0.402 | 0.3871 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0176 | 0.4627 | 0.5 |
Echinococcus multilocularis | tar DNA binding protein | 0.0134 | 0.3192 | 1 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.0334 | 1 | 1 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0125 | 0.2903 | 0.9061 |
Trichomonas vaginalis | chromobox protein, putative | 0.0077 | 0.1267 | 1 |
Brugia malayi | Heterochromatin protein 1 | 0.0077 | 0.1267 | 0.3968 |
Entamoeba histolytica | hypothetical protein | 0.004 | 0 | 0.5 |
Schistosoma mansoni | chromobox protein | 0.0077 | 0.1267 | 0.3968 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0073 | 0.1143 | 0.3582 |
Brugia malayi | TAR-binding protein | 0.0134 | 0.3192 | 1 |
Onchocerca volvulus | Heterochromatin protein 1 homolog | 0.0046 | 0.0227 | 1 |
Schistosoma mansoni | chromobox protein | 0.0077 | 0.1267 | 0.3968 |
Schistosoma mansoni | tar DNA-binding protein | 0.0134 | 0.3192 | 1 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0134 | 0.3192 | 1 |
Trichomonas vaginalis | chromobox protein, putative | 0.0046 | 0.0227 | 0.0969 |
Brugia malayi | RNA binding protein | 0.0134 | 0.3192 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0134 | 0.3192 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0073 | 0.1143 | 0.3582 |
Entamoeba histolytica | hypothetical protein | 0.004 | 0 | 0.5 |
Trichomonas vaginalis | chromobox protein, putative | 0.0046 | 0.0227 | 0.0969 |
Schistosoma mansoni | tar DNA-binding protein | 0.0134 | 0.3192 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.